CLOV vs ESPR
Clover Health Investments Corp (CLOV) versus Esperion Therapeutics Inc (ESPR) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
CLOV currently screens at market cap $1.55B. ESPR currently screens at market cap $816.9M.
Not investment advice. Open the CLOV and ESPR stock pages for the full models.
Not investment advice.